194 related articles for article (PubMed ID: 28262196)
21. Elevated chemerin levels in Pakistani men: an interrelation with metabolic syndrome phenotypes.
Fatima SS; Bozaoglu K; Rehman R; Alam F; Memon AS
PLoS One; 2013; 8(2):e57113. PubMed ID: 23468920
[TBL] [Abstract][Full Text] [Related]
22. Hepatic chemerin mRNA in morbidly obese patients with nonalcoholic fatty liver disease.
Kajor M; Kukla M; Waluga M; Liszka Ł; Dyaczyński M; Kowalski G; Żądło D; Berdowska A; Chapuła M; Kostrząb-Zdebel A; Bułdak RJ; Sawczyn T; Hartleb M
Pol J Pathol; 2017; 68(2):117-127. PubMed ID: 29025245
[TBL] [Abstract][Full Text] [Related]
23. Lipid profile pattern in pediatric overweight population with or without NAFLD in relation to IDF criteria for metabolic syndrome: a preliminary study.
Bălănescu A; Bălănescu P; Comănici V; Stan I; Acs B; Prisăcariu L; Brezan F; Ciomârtan T; Gherghina I
Rom J Intern Med; 2018 Mar; 56(1):47-54. PubMed ID: 29080393
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic Effect of Metformin on Chemerin in Non-Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
Zhuang X; Sun F; Li L; Jiang D; Li X; Sun A; Pan Z; Lou N; Zhang L; Lou F
Clin Lab; 2015; 61(10):1409-14. PubMed ID: 26642701
[TBL] [Abstract][Full Text] [Related]
25. [Chemerin as an early marker of metabolic syndrome].
Roguska J; Zubkiewicz-Kucharska A
Pediatr Endocrinol Diabetes Metab; 2018; 24(1):45-51. PubMed ID: 30083661
[TBL] [Abstract][Full Text] [Related]
26. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.
Sell H; Divoux A; Poitou C; Basdevant A; Bouillot JL; Bedossa P; Tordjman J; Eckel J; Clément K
J Clin Endocrinol Metab; 2010 Jun; 95(6):2892-6. PubMed ID: 20375212
[TBL] [Abstract][Full Text] [Related]
27. Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial.
Saneian H; Khalilian L; Heidari-Beni M; Khademian M; Famouri F; Nasri P; Hassanzadeh A; Kelishadi R
J Pediatr Endocrinol Metab; 2021 Jul; 34(7):897-904. PubMed ID: 33939897
[TBL] [Abstract][Full Text] [Related]
28. Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.
Zhang Z; Wang J; Wang H
Exp Ther Med; 2018 Mar; 15(3):2936-2940. PubMed ID: 29456698
[TBL] [Abstract][Full Text] [Related]
29. Nocturnal levels of chemerin and progranulin in adolescents: influence of sex, body mass index, glucose metabolism and sleep.
Daxer J; Herttrich T; Zhao YY; Vogel M; Hiemisch A; Scheuermann K; Körner A; Kratzsch J; Kiess W; Quante M
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):57-61. PubMed ID: 27941174
[TBL] [Abstract][Full Text] [Related]
30. Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease.
Ye Z; Wang S; Yang Z; He M; Zhang S; Zhang W; Wen J; Li Q; Huang Y; Wang X; Lu B; Zhang Z; Su Q; Hu R
Mol Biol Rep; 2014 Mar; 41(3):1317-23. PubMed ID: 24390241
[TBL] [Abstract][Full Text] [Related]
31. Higher levels of circulating chemerin in both lean and obese patients with polycystic ovary syndrome.
Ademoglu E; Berberoglu Z; Carlioglu A; Dellal F; Gorar S; Alphan Z; Uysal S; Karakurt F
Minerva Ginecol; 2014 Dec; 66(6):535-42. PubMed ID: 25373013
[TBL] [Abstract][Full Text] [Related]
32. Serum Fetuin-A levels in obese children with biopsy proven nonalcoholic fatty liver disease.
Pampanini V; Inzaghi E; Germani D; Alterio A; Puglianiello A; Alisi A; Nobili V; Cianfarani S
Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):71-76. PubMed ID: 29122442
[TBL] [Abstract][Full Text] [Related]
33. Biochemical Predictors of Early Onset Non-Alcoholic Fatty Liver Disease in Young Children with Obesity.
Kim JY; Cho J; Yang HR
J Korean Med Sci; 2018 Apr; 33(16):e122. PubMed ID: 29651819
[TBL] [Abstract][Full Text] [Related]
34. [The expression of chemerin and the influence of sitagliptin on its expression in non-alcoholic fatty liver disease rats complicated with prediabetes].
Zhang L; Gao XF; Wang YH
Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2407-2413. PubMed ID: 30138985
[No Abstract] [Full Text] [Related]
35. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
36. A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents.
Wojcik M; Janus D; Dolezal-Oltarzewska K; Kalicka-Kasperczyk A; Poplawska K; Drozdz D; Sztefko K; Starzyk JB
J Pediatr Endocrinol Metab; 2012; 25(11-12):1089-93. PubMed ID: 23329754
[TBL] [Abstract][Full Text] [Related]
37. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
[TBL] [Abstract][Full Text] [Related]
38. Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis.
Yoo HJ; Hwang SY; Choi JH; Lee HJ; Chung HS; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
PLoS One; 2017; 12(4):e0174717. PubMed ID: 28376109
[TBL] [Abstract][Full Text] [Related]
39. Leptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease.
Angın Y; Arslan N; Kuralay F
Turk J Pediatr; 2014; 56(3):259-66. PubMed ID: 25341597
[TBL] [Abstract][Full Text] [Related]
40. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
